Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism

BACKGROUND: Acquisition of the chemoresistance to docetaxel (DTX), a microtubule-targeting agent, has been a huge obstacle in treatment for metastatic castration-resistant prostate cancer (mCRPC). Recently, strategies targeting the mitosis error correction mechanism including chromosomal passenger c...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liang, Song, Yarong, Hou, Teng, Li, Xuexiang, Cheng, Lulin, Li, Yunxue, Xing, Yifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166435/
https://www.ncbi.nlm.nih.gov/pubmed/35659274
http://dx.doi.org/10.1186/s13046-022-02404-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166435/
https://www.ncbi.nlm.nih.gov/pubmed/35659274
http://dx.doi.org/10.1186/s13046-022-02404-3

Ejemplares similares